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In this issue of Structure, Ulens and colleagues demonstrate how an elegant combination of complementary
functional and structural approaches can uncover both binding sites and conformational consequences
associated with the Alzheimer’s drug memantine binding to an ion channel.A hallmark of neuronal activity is the fasci-
nating ability of neurons to exchange in-
formation with remarkable speed and
precision. Nowhere is this better illus-
trated than at the synapse, the cellular
equivalent of a relay station. The presyn-
aptic cell is faced with the daunting chal-Figure 1. ELIC F16’S Bound to Br-Memantine: 4TWH
Only two of the five ELIC subunits are shown for clarity. Three Br-memantine
molecules are shown to highlight their simultaneous occupancy of the channel
pore in the TMD as well as the orthosteric binding sites in the LBD.lenge to communicate urgent
news, i.e., the arrival of an ac-
tion potential to its neighbor,
the postsynaptic cell. The
predominant solution to
bridge the void between the
cells, the so-called synaptic
cleft, is by way of electrically
induced neurotransmitter
release by the presynaptic
cell. This conversion from an
electrical to a chemical signal
is immediately reversed
again when the neurotrans-
mitter, after traveling across
the cleft, binds to its target re-
ceptor in the postsynaptic
membrane. This triggers the
opening of a pore within the
receptor, resulting in ionic
flux across the postsynaptic
membrane and therefore in
a change of the electrical
excitability of the postsyn-
aptic cell.
Understanding this intri-
cate process has not only
posed a formidable challenge
for decades, but its pharma-
cological modulation forms a
potent means of rectifying
pathophysiological neuronal
activity. This is particularly
true for the above postsyn-
aptic receptors, a large class
of ion channels including thepentameric ligand-gated ion channels
(pLGICs). Neurotransmitter binding to
the pLGIC extracellular ligand-binding
domain (LBD) is thought to trigger a series
of conformational changes that subse-
quently open the channel pore in the
transmembrane domain (TMD) (Figure 1).Structure 22, October 7, 2014Given their central role in fast synaptic
transmission and the ever increasing
number of disease states associated
with these receptors, it is not surprising
that pLGICs are the target of numerous
clinically relevant drugs that can initiate,
modulate, or block their activity.ª2014 ElsevOne such therapeutic,
memantine, is clinically used
for the management of Alz-
heimer’s disease symptoms.
It is believed that memantine
elicits its function by inhibiting
ligand-gated ion channels.
However, the molecular de-
tails of how drug binding
results in the functional inhibi-
tion remained enigmatic. In
this issue of Structure, Ulens
et al. (2014) present the X-ray
crystal structure of ELIC, a
prokaryotic pLGIC, in the
presence and absence
of memantine, providing the
first example of a closed
pLGIC pore in a blocker-
bound conformation. Intrigu-
ingly, the data suggest that
memantine not only binds in
the upper half of the TMD,
thereby exerting its blocking
effect, but also that meman-
tine binds in the orthosteric
ligand-binding pocket in the
LBD, a site usually highly
selective in the recognition of
the cognate neurotransmitter.
While the identification of
more than one binding site
for a small molecule modu-
lator or inhibitor may not
come as a big surprise
(Hamouda et al., 2014), it isier Ltd All rights reserved 1373
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question is able to show up in the two
most sacred spots of the receptor: its
pore and its orthosteric binding site. This
constitutes an interesting complement to
the often complex effects of channel
blockers on pLGICs observed in func-
tional electrophysiology experiments,
which was also found by the authors in
the case of memantine and ELIC. In fact,
this may not be dissimilar from the finding
that nicotinic acetycholine receptors are
both activated and (at higher concentra-
tions) blocked by a range of ligands
(Sine and Steinbach, 1984). The current
study therefore sheds new structural light
on this long-standing observation and
may well trigger renewed interest in this
fascinating phenomenon.
The pLGIC field has greatly benefitted
from a recent surge in available crystal
structures, first by bacterial pLGIC homo-
logs (reviewed in Corringer et al., 2012)
and later followed by eukaryotic pLGICs
(Althoff et al., 2014; Hassaine et al.,
2014; Hibbs and Gouaux, 2011; Miller
and Aricescu, 2014). The present study
therefore adds to an already astounding
number of crystallographically observed1374 Structure 22, October 7, 2014 ª2014 Elpore conformations among pLGICs.
However, the authors also point out an
intriguing twist in the story; although
the structurally determined closed pore
conformation is uncannily similar under
memantine-free and memantine-bound
conditions, their data from combined
electrophysiological and fluorescence
measurements suggest that memantine
induces a conformational state distinct
from that of the agonist-free (and likely
also the agonist-bound) receptor. This is
an important finding, because it suggests
that the entire conformational landscape
visited by the protein in an intact mem-
brane may, in some cases, lie beyond
the grasp of X-ray crystal structures.
Interestingly, this is in good agreement
with another recent crystallography study
on ELIC, in which the authors found that
significant functional changes failed to
translate into crystallographically observ-
able structural changes of the protein
(Gonzalez-Gutierrez et al., 2012).
It will be fascinating to see what combi-
nations of structural and functional ap-
proaches eventually uncover the whole
range of conformational states and transi-
tions in pLGICs and other ion channels.sevier Ltd All rights reservedREFERENCES
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The helical protein MLKL inserts into cell membranes and forms a permeation pore therein, resulting in cell
death. In this issue of Structure, the article by Su and colleagues reports that helix 6 regulates the opening of
the pore formed by preceding core helices.Under disease-induced stress, cells
launch a suicide protocol that activates
formation of a permeation pore in the cell
membrane. The pore is formed by the
MLKL protein and allows osmotic swelling
and rupture, ultimately leading to cell
death. This process is called necroptosis,
an emerging form of programmed cell
deaths, which is different from its well-
known rhyming cousin apoptosis (Sunet al., 2012;Wanget al., 2014). In this issue
of Structure, the article by Su et al. (2014)
provides critical insights into how MLKL
forms the pore in the membrane and,
more importantly, how the pore is regu-
lated at a molecular level.
MLKL belongs to a class of proteins that
are expressed as soluble polypeptides but
insert into the membrane to form perme-
ation pores or channels. They include bac-terial toxins such as colicin and diphtheria
toxin as well as the Bak/Bax proteins,
which play an essential role in apotosis. In
MLKL, the N-terminal membrane binding
domain (MBD) is connected to theC-termi-
nal regulatory domain, whose phosphory-
lation status regulates the opening of the
pore (Su et al., 2014; Wang et al., 2014).
Using nuclear magnetic resonance
(NMR) spectroscopy, Su et al. (2014) found
